Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Introduction: emerging role of epigenetic therapy: focus on decitabine.

× No keyword cloud information.

5 in total

Review 1. A decade of exploring the cancer epigenome - biological and translational implications.

Authors: Stephen B Baylin; Peter A Jones
Journal: Nat Rev Cancer Date: 2011-09-23 Impact factor: 60.716

2. The third-time chronic myeloid leukemia in lymphoblastic crisis with ABL1 kinase mutation induced by decitabine, dexamethason combined with nilotinib and dasatinib.

Authors: Suli Wang; Chun Qiao; Yu Zhu; Wenyi Shen; Guangsheng He; Jianyong Li
Journal: J Transl Int Med Date: 2016-12-30

Review 3. The future of epigenetic therapy in solid tumours--lessons from the past.

Authors: Nilofer Azad; Cynthia A Zahnow; Charles M Rudin; Stephen B Baylin
Journal: Nat Rev Clin Oncol Date: 2013-04-02 Impact factor: 66.675

4. Decitabine for the treatment of atypical chronic myeloid leukemia: A report of two cases.

Authors: Huifang Jiang; Zhonglin Wu; L I Ren; Diehong Tao; Hongyan Tong
Journal: Oncol Lett Date: 2015-11-25 Impact factor: 2.967

5. Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for Cancer.

Authors: Nidal E Muvarak; Khadiza Chowdhury; Limin Xia; Carine Robert; Eun Yong Choi; Yi Cai; Marina Bellani; Ying Zou; Zeba N Singh; Vu H Duong; Tyler Rutherford; Pratik Nagaria; Søren M Bentzen; Michael M Seidman; Maria R Baer; Rena G Lapidus; Stephen B Baylin; Feyruz V Rassool
Journal: Cancer Cell Date: 2016-10-10 Impact factor: 31.743

5 in total